Tuberculosis (TB) is a bacterial infection that spreads through the air when someone with active TB coughs, sneezes, or speaks. The disease primarily affects the lungs, though it can develop in other parts of the body. According to the CDC, TB remains a significant public health concern in the United States, with approximately 7,000 to 8,000 reported cases annually across all 50 states. While these numbers may seem small compared to the overall U.S. population, TB is serious because it can be life-threatening if left untreated.
Learn About Paying Your FGUA Bill Online →
Understanding TB testing is important because the infection exists in two forms: latent TB infection and active TB disease. A person with latent TB infection carries the bacteria but shows no symptoms and cannot spread the disease to others. However, without treatment, latent TB can progress to active disease in about 5-10% of infected people. Active TB disease causes symptoms like persistent cough lasting more than three weeks, chest pain, fatigue, fever, and night sweats. Testing helps distinguish between these two states and informs next steps.
TB testing also matters because certain groups face higher risk. People born in countries with high TB rates, healthcare workers, those living in congregate settings like shelters or correctional facilities, and people with weakened immune systems face greater exposure risk. Additionally, racial and ethnic disparities exist in TB rates, with Black and Hispanic populations experiencing higher burdens of disease in many parts of the country.
Our TB test information guide explores how testing works, who should consider getting tested, what different test results mean, and where to find testing resources in your community. The guide focuses on making the testing process less confusing by breaking down medical terminology and explaining practical steps. Whether you think you may have been exposed to TB or want to understand your testing options, this resource presents the key information you need to make informed decisions about your health.
Practical takeaway: TB is a treatable condition, but only when people understand what testing options exist and how the results guide care decisions. This guide provides that foundational knowledge.
TB testing relies on two primary methods: the tuberculin skin test (TST), also called the Mantoux test, and interferon-gamma release assays (IGRAs). Understanding the difference between these tests matters because they work differently and may be recommended for different situations.
Free Guide to Pay by Plate Illinois Billing →
The tuberculin skin test involves injecting a small amount of purified protein derivative (PPD) just under the skin, typically on the forearm. The injection itself causes minimal discomfort—most people describe it as a slight pinch. The critical part happens 48 to 72 hours later when a healthcare provider examines the injection site. If a raised, firm area (called an induration) appears around the injection spot, the test is considered positive, indicating TB infection. The size of the induration matters; different measurements indicate different levels of TB risk depending on your personal risk factors. A flat or very small reaction suggests a negative test. TST remains widely used because it is inexpensive, costs typically ranging from $10 to $20, and works well for screening large groups of people.
Interferon-gamma release assays represent a newer approach. These blood tests measure how the immune system reacts to TB antigens in a laboratory setting. A healthcare provider draws blood into special test tubes containing TB antigens, then the sample goes to a lab where technicians observe the immune response. Results typically come back within 24 to 48 hours. IGRAs cost more than TST—usually $50 to $100—but offer advantages for certain people, particularly those who have received the BCG vaccine (common outside the United States) or those with conditions making TST interpretation difficult.
Both tests detect TB infection but cannot distinguish between latent and active disease on their own. A positive TB test must be followed by additional evaluation, usually a chest X-ray and possibly a medical interview, to determine whether someone has latent TB infection or active TB disease. This distinction is crucial because treatment differs significantly between the two forms.
Practical takeaway: Knowing which test type you receive and what happens next helps you understand whether you need follow-up evaluation and why healthcare providers choose specific testing approaches for different situations.
TB test results come back as either positive or negative, but these words carry specific meanings that differ from everyday language. A negative result means no TB infection was detected, suggesting you either have not been exposed to TB or your immune system successfully fought off exposure. For people with negative results and no TB symptoms, further TB-related testing is not needed unless future exposure occurs.
Free Guide to Mold Removal Methods for Walls →
A positive TB test result means your immune system reacted to TB antigens, indicating TB infection is present. However—and this is critical—a positive test alone does not mean you have active TB disease. Most people with positive TB tests have latent TB infection, meaning they carry the bacteria but are not sick and cannot spread TB to others. Approximately 85% to 90% of people with latent TB infection never develop active disease. A positive test signals that you need further evaluation to determine which type of TB infection you have and whether treatment is necessary.
After a positive TB test, healthcare providers typically order a chest X-ray to look for signs of active TB disease in the lungs. The X-ray results combined with your medical history, symptoms (or lack thereof), and sometimes additional tests help clarify your TB status. If the chest X-ray shows no signs of active disease and you have no TB symptoms like cough, fever, or night sweats, you likely have latent TB infection. People with latent TB infection may be offered preventive treatment to reduce the risk of the infection progressing to active disease.
Certain results require specific follow-up timelines. If your test is positive and a chest X-ray shows active TB disease—indicated by findings like cavitary lesions or infiltrates—you need prompt medical evaluation and likely treatment initiation. A person with active TB disease is contagious and can spread the disease to others, making timely care essential. In contrast, people with latent TB infection are not contagious, so there is less urgency, though treatment is still recommended for many people to prevent future progression.
Some people receive inconclusive or indeterminate results, particularly with IGRA blood tests. This outcome means the test did not clearly indicate TB infection or no infection. In these cases, healthcare providers may repeat the test, order a TST if an IGRA was done initially, or recommend follow-up testing at a later date. Indeterminate results occur in a small percentage of tests and do not necessarily mean anything is wrong with you—they simply mean the test result was not definitive.
Practical takeaway: A positive TB test is not a diagnosis of active disease; it is a signal to pursue additional evaluation. Understanding this distinction reduces anxiety and helps you engage appropriately with follow-up care.
TB testing recommendations depend on individual circumstances and risk factors. The CDC and health departments across the country use risk-based approaches to guide testing recommendations, recognizing that not everyone needs the same screening strategy.
How to Delete Your Fitbit Account Guide →
Certain situations create higher testing importance. People who have had close contact with someone diagnosed with active TB disease should get tested, ideally soon after the exposure is identified. Healthcare workers and people employed in settings where TB exposure is possible—such as homeless shelters, correctional facilities, nursing homes, or hospitals—often receive testing as part of employment requirements or regular occupational health screening. People born in countries with high TB incidence, or who have lived in those countries for extended periods, should consider testing even if they currently live in the United States, as TB can develop years after initial infection.
Certain medical conditions also warrant TB testing. People with HIV infection face significantly higher risk of TB progressing to active disease if infected, making testing particularly important for this group. People taking immunosuppressive medications for autoimmune conditions or following organ transplants should discuss TB testing with their healthcare providers. People with diabetes, chronic kidney disease, or malnutrition also face elevated TB risk. Additionally, people with a history of TB or those with old, inactive TB findings on previous chest X-rays may need testing or monitoring.
Specific life events or situations prompt testing recommendations. Before starting certain medications, particularly those that suppress immune function, TB testing may be required. People moving to congregate living situations or entering the military often receive TB testing as a standard part of intake procedures. Women planning pregnancy may be counseled about TB testing to ensure infection status is known before conception. Some healthcare
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.